| 
Research
program : the canine dilated cardiomyopathy.
The
main objectives are :
•
clear
the transmission mode of pathology by analyzing pedigrees,
•
collect
DNA samples of dogs (affected and not) in order to
research the gene(s) and mutation(s) responsible for DCM,
•
develop
a genetic test for diagnosis if possible. This test would
be useful for the breeders to detect DCM earlier and help
them in their selection policy.
To
carry out this research, all information on the genealogy
and the clinical status of the dogs would be useful (copy
of cardiac examination and pedigree). Blood samples will be
necessary on both affected and healthy dogs.
The
canine dilated cardiomyopathy (usually called DCM) is a genetic
disease that affects various canine breeds of wich
Irish Wolfhound (Dobermann, Boxer, Newfoundland,
Great Dane, Cocker and more too). This affection results in
a dilation of cardiac cavities and a thinning of the cardiac
walls. This affection leads to cardiac insuffiency. In many
cases, the death of the dog occurs suddenly.
The
first clinical signs of DCM, when they can be recognized,
are intolerance to exercise and loss of weight. Dogs may cough
and have respiratory difficulties, muscular weakness, abdominal
distension or faintness. Furthermore, the cardiac auscultation
frequently reveals heart murmur and/or arrhythmias.
Diagnosis
of this disease is realised by a veterinary surgeon who practices
an auscultation with specific examinations as echocardiography,
Doppler and electrocardiography.
A
genetic origin is suspected for this illness. Although the
monogenic or polygenic character (one or more gene affected)
is not simple to highlight. Nevertheless, in certain breeds,
an alteration in a single gene could lead to the disease.
In
2006, ANTAGENE and its collaborators began to develop a research
program on DCM of Irish Wolfhound. Since
2008, this program has been included in a wide European project
(LUPA). Thanks to this project, Dog profit of high
technological platform and resources to discover genetic causes
of many inherited disorders. LUPA gathers efforts of European
researchers (22 teams in 11 countries) and gives a real opportunity
to progress in the understanding of the genetic cause of the
disease.
Program about DCM requires blood samples
in order to extract DNA with high quantity and quality.
We
collaborate with :
- canine associations and breeders (RALIE,…),
- veterinary surgeons specialized in Cardiology (Studying
Group of Cardiology of the French Association of Vets for
Pets,…),
- the veterinary school of Alfort (Cardiology Unit, UMR955
ENVA-INRA).
We
remind that this work will be undertaken in total confidentiality
by ANTAGENE. No personal result will be communicated to the
stockbreeders during and at the end of this research program.
Furthermore no financial participation is required.
Project manager : Dr Anne Thomas (athomas@antagene.com)
Contact for sampling program : Jérôme Mary (jmary@antagene.com)
Information
on www.antagene.com
ANTAGENE
LABORATOIRE DE RECHERCHE ET D’ANALYSES EN GÉNOMIQUE
ANIMALE
Immeuble Le Meltem - 2, allée des Séquoias -
69760 Limonest - France
Tél : 33 (0)4 37 49 90 03 - Fax : 33 (0)4 37 49 04
89
www.antagene.com
- antagene@antagene.com
|